Cécile Ronckers

Dr. Ronckers
Current position:Scientific personnel
Specialist field:Biometrie und Registerforschung
Office address:

Institut für Biometrie und Registerforschung
Fehrbelliner Straße 38
16816 Neuruppin

Office phone number:+49 3391 39 14590
Curriculum Vitae

Dr. Cécile Ronckers holds a Master’s Degree in Health Sciences (Maastricht University, 1995) and a PhD in Epidemiology (Vrije Universiteit Amsterdam, 2001). Further training and research experience in risk modelling, radiation sciences, cancer epidemiology, and survivorship studies was obtained at the U.S. National Cancer Institute (1999-2006). She continued survivorship research at the Emma Children’s Hospital/AMC Amsterdam, embedded in the national LATER Study Group. In 2018 her ongoing research line on subsequent tumors and radiotherapy-related side effects was integrated into the new Princess Máxima Center for Pediatric Oncology in Utrecht (The Netherlands). She is an active member of trans-Atlantic consortia (PENTEC, IGHG) to summarize and translate scientific evidence into recommendations for care, and she serves as Board Member of the European PanCare Consortium. In 2019, she joined the Brandenburg Medical School in a dual position as Project Coordinator for a project about various aspects of second opinion procedures in the German health care system from patients’ and physicians’ perspectives (ZWEIT), and as Senior Researcher in the Institute for Biostatistics and Registry Research. For a complete CV, click here.


Teepen JC, Kok JL, Kremer LC, Tissing WJ, Van den Heuvel-Eibrink MM, Loonen JJ, Bresters D, Van der Pal HJ, Versluys B, Van Dulmen-den Broeder E, Nijsten T, Hauptmann M, Hollema N, Dolsma WV, Van Leeuwen FE, Ronckers CM, DCOG-LATER Study Group. Long-term risk of skin cancer among childhood cancer survivors: a DCOG-LATER cohort study. J Natl Cancer Inst 2019; 111(8): 845–853.

Meulepas JM, Ronckers CM, Smets AM, Nievelstein RA, Gradowska P, Lee C, Jahnen A, Van Straten M, De Wit MC, Zonnenberg B, Klein WM, Merks JH, Visser O, Van Leeuwen FE, Hauptmann M. Radiation exposure from pediatric CT scans and subsequent cancer risk in the Netherlands. J Natl Cancer Inst 2019; 111(3): 256–263.

Constine LS, Ronckers CM, Hua CH, Olch A, Kremer LCM, Jackson A, Bentzen SM. Pediatric normal tissue effects in the clinic (PENTEC): An international collaboration to analyse normal tissue radiation dose-volume response relationships for paediatric cancer patients. Clin Oncol (R Coll Radiol) 2019; 31: 199–207.

Teepen JC, Ronckers CM, Kremer LCM. Colorectal cancer screening in childhood cancer survivors (editorial). J Natl Cancer Inst 2019, 111(11): djz063.

Kok JL, Teepen JC, Van Leeuwen FE, Tissing WJE, Neggers SJCMM, Van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Van den Heuvel-Eibrink MM, Van Dulmen-den Broeder E, Van der Heiden-van der Loo M, Aleman BMP, Daniels LA, Haasbeek CJA, Hoeben B, Janssens GO, Maduro JH, Oldenburger F, Van Rij C, Tersteeg RJHA, Hauptmann M; DCOG-LATER Study Group, Kremer LCM, Ronckers CM. Risk of benign meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age. Neuro Oncol 2019; 21(3): 392–403.

Teepen JC, Kok JL, Van Leeuwen FE, Tissing WJE, Dolsma WV, Van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Van den Heuvel-Eibrink MM, Van Dulmen-den Broeder E, Van den Berg MH, Van der Heiden-van der Loo M, Hauptmann M, Jongmans MC, Overbeek LI, Van de Vijver MJ, Kremer LCM, Ronckers CM; DCOG-LATER Study Group. Colorectal adenomas and cancers after childhood cancer treatment: A DCOG-LATER Record Linkage Study. J Natl Cancer Inst 2018; 110(7): 758–767.

Bright CJ, Hawkins MM, Winter DL, Alessi D, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Byrne J, Feijen EAM, Fidler MM, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Haddy N, Jankovic M, Kaatsch P, Kaiser M, Kuehni CE, Linge H, Øfstaas H, Ronckers CM, Skinner R, Teepen JC, Terenziani M, Vu-Bezin G, Wesenberg F, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuonen R, Winther JF, de Vathaire F, Kremer LC, Hjorth L, Reulen RC; PanCareSurFup Consortium. Risk of soft-tissue sarcoma among 69, 460 5-year survivors of childhood cancer in Europe. J Natl Cancer Inst 2018; 110(6): 649–660.

Turcotte LM, Neglia JP, Reulen RC, Ronckers CM, Van Leeuwen FE, Morton LM, Oeffinger KC, Henderson TO. Risk factors and surveillance of subsequent malignant neoplasms in childhood cancer survivors: A Review. J Clin Oncol 2018; 36: 2145–2152.

Teepen JC, Van Leeuwen FE, Tissing WJ, Van Dulmen-den Broeder E, Van den Heuvel-Eibrink MM, Van der Pal HJ, Loonen JJ, Bresters D, Versluys B, Neggers SJCMM, Jaspers MWM, Hauptmann M, Van der Heiden-van der Loo M, Visser O, Kremer LCM, Ronckers CM; DCOG LATER Study Group. Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER Study Cohort: Role of chemotherapy. J Clin Oncol 2017; 35(20): 2288–2298.

Meulepas JM, Smets AMJB, Nievelstein RAJ, Gradowska P, Verbeke J, Holscher HC, Rutten MJCM, Kieft M, Ronckers CM, Hauptmann M. Trends and patterns of computed tomography scan use among children in the Netherlands: 1990-2012. Eur Radiol 2017; 27(6): 2426–2433.

Meulepas JM, Ronckers CM, Merks J, Weijerman ME, Lubin JH, Hauptmann M. Confounding of the association between radiation exposure from CT scans and risk of leukemia and brain tumors by cancer susceptibility syndromes. J Radiol Prot 2016; 36(4): 953–974.

Teepen JC, De Vroom SL, Van Leeuwen FE, Tissing W, Kremer LCM, Ronckers CM. Risk of subsequent gastrointestinal tract cancer among childhood cancer survivors: A systematic review. Cancer Treat Rev 2016; 43: 92-103.

Van Leeuwen FE. Ronckers CM. Anthracyclines and alkylating agents: new risk factors for breast cancer in childhood cancer survivors? (Editorial). J Clin Oncol 2016; 34: 891-894.